Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment.
He S, Chu X, Wu Y, Jiang J, Fang P, Chen Y, Liu Y, Qiu Z, Xiao Y, Li Z, Pan D, Zhang Q, Xie H, Xing S, Feng F, Liu W, Guo Q, Zhao L, Yang P, Sun H.
He S, et al. Among authors: chen y.
J Med Chem. 2023 Jul 27;66(14):9537-9560. doi: 10.1021/acs.jmedchem.3c00213. Epub 2023 Jul 6.
J Med Chem. 2023.
PMID: 37409679